Fujishima, Naohito
Uchida, Toshiki
Onishi, Yasushi
Jung, Chul Won
Goh, Yeow Tee
Ando, Kiyoshi
Wang, Ming Chung
Ono, Chiho
Matsumizu, Miyako
Paccagnella, M. Luisa
Sleight, Barbara
Vandendries, Erik
Fujii, Yosuke
Hino, Masayuki
Funding for this research was provided by:
Pfizer (Not applicable)
Article History
Received: 27 June 2019
Revised: 24 September 2019
Accepted: 25 September 2019
First Online: 13 November 2019
Compliance with ethical standards
:
: Naohito Fujishima: Honoraria (Pfizer). Toshiki Uchida: Honoraria (Janssen, Pfizer). Yasushi Onishi: research funding (BMS, MSD, Takeda). Chul Won Jung: no disclosures to report. Yeow Tee Goh: no disclosures to report. Kiyoshi Ando: Research funding (Celgene, Astellas, Novartis, Otsuka, Eisai, Boehringer Ingelheim, MSD, Ono, IQVIA), subsidies or donations (Novartis, Meiji Seika, Kyowa Hakko Kirin, Eisai, Takeda, Mochida). Ming Chung Wang: no disclosures to report. Chiho Ono: employment (Pfizer). Miyako Matsumizu: employment (Pfizer). M. Luisa Paccagnella: employment (Pfizer), stock ownership (Pfizer). Barbara Sleight: employment (Pfizer), stock ownership (Pfizer). Erik Vandendries: Employment (Pfizer), stock ownership (Pfizer). Yosuke Fujii: employment (Pfizer). Masayuki Hino: Honoraria (Pfizer), subsidies or donations (Pfizer, Kyowa Hakko Kirin, Chugai, Astellas, Taiho, Ono, JB).